See also this year's filing and all EDGAR filings for this company.
PDF Report 0001208261_2014_Immune_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001208261, Immune Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 267,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,606,758 |
| 2 | PropertyPlantAndEquipmentNet | 47,000 |
| 3 | remainder_Assets | 27,580,242 |
| 4 | LiabilitiesCurrent | 11,268,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 14,750,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,448,000 |
| 9 | ResearchAndDevelopmentExpense | 3,571,000 |
| 10 | remainder_Expenses | 11,000 |
| 11 | remainder_Revenues | 19,000 |
| 12 | remainder_NetIncome | 3,251,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 31,501,000 |
| 1 | Liabilities | 26,018,000 |
| 2 | Expenses | 9,030,000 |
| 3 | Revenues | 19,000 |
| 4 | StockholdersEquity | 5,483,000 |
| 5 | NetIncome | -5,760,000 |
| 6 | ComprehensiveNetIncome | -5,760,000 |
| 7 | BaseVar | 34,909,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.215 |
| 9 | EconomicCapitalRatio | 1.62 |
Edgar->Model Mapping
Feature Distribution
Change over Time
